62856-220Level 3
LECANEMAB AUTOINJECTOR (lecanemab-irmb)
**Product type:** Human Prescription Drug
**Active ingredient:** LECANEMAB-IRMB
**Strength:** 200 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Eisai Inc.
**Marketing category:** BLA (BLA761375)
**Pharmacologic class:** Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]
GET
/api/v1/systems/ndc_fda/nodes/62856-220Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.